Pleuropulmonary blastoma

Revision as of 02:15, 6 November 2017 by Mmir (talk | contribs) (Mahshid)
Jump to navigation Jump to search

WikiDoc Resources for Pleuropulmonary blastoma

Articles

Most recent articles on Pleuropulmonary blastoma

Most cited articles on Pleuropulmonary blastoma

Review articles on Pleuropulmonary blastoma

Articles on Pleuropulmonary blastoma in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Pleuropulmonary blastoma

Images of Pleuropulmonary blastoma

Photos of Pleuropulmonary blastoma

Podcasts & MP3s on Pleuropulmonary blastoma

Videos on Pleuropulmonary blastoma

Evidence Based Medicine

Cochrane Collaboration on Pleuropulmonary blastoma

Bandolier on Pleuropulmonary blastoma

TRIP on Pleuropulmonary blastoma

Clinical Trials

Ongoing Trials on Pleuropulmonary blastoma at Clinical Trials.gov

Trial results on Pleuropulmonary blastoma

Clinical Trials on Pleuropulmonary blastoma at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Pleuropulmonary blastoma

NICE Guidance on Pleuropulmonary blastoma

NHS PRODIGY Guidance

FDA on Pleuropulmonary blastoma

CDC on Pleuropulmonary blastoma

Books

Books on Pleuropulmonary blastoma

News

Pleuropulmonary blastoma in the news

Be alerted to news on Pleuropulmonary blastoma

News trends on Pleuropulmonary blastoma

Commentary

Blogs on Pleuropulmonary blastoma

Definitions

Definitions of Pleuropulmonary blastoma

Patient Resources / Community

Patient resources on Pleuropulmonary blastoma

Discussion groups on Pleuropulmonary blastoma

Patient Handouts on Pleuropulmonary blastoma

Directions to Hospitals Treating Pleuropulmonary blastoma

Risk calculators and risk factors for Pleuropulmonary blastoma

Healthcare Provider Resources

Symptoms of Pleuropulmonary blastoma

Causes & Risk Factors for Pleuropulmonary blastoma

Diagnostic studies for Pleuropulmonary blastoma

Treatment of Pleuropulmonary blastoma

Continuing Medical Education (CME)

CME Programs on Pleuropulmonary blastoma

International

Pleuropulmonary blastoma en Espanol

Pleuropulmonary blastoma en Francais

Business

Pleuropulmonary blastoma in the Marketplace

Patents on Pleuropulmonary blastoma

Experimental / Informatics

List of terms related to Pleuropulmonary blastoma

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2], Maria Fernanda Villarreal, M.D. [3]

Synonyms and keywords: Pulmonary blastoma; PPB

Overview

Pleuropulmonary blastoma (PPB) is a rare intrathoracic malignancy originating in the lung or pleural cavity. Pleuropulmonary blastoma occurs most often in infants and young children.[1] The pathogenesis of pleuropulmonary blastoma is characterized by resembling immature lung tissue. The p53 mutations/deletions have been associated with the development of pleuropulmonary blastoma. Pleuropulmonary blastoma may be classified into 3 groups: type I, II, III. Common causes of pleuropulmonary blastoma include trisomy 8, trisomy 2, and p53 mutations/deletions (e.g., Li-Fraumeni syndrome). On gross pathology, characteristic findings of pleuropulmonary blastoma include extra-pulmonary location, and attachment to the parietal pleura. Pleuropulmonary blastoma is more commonly observed among patients between 0-2 years old. Complete surgical resection is often most common approach to the treatment of pleuropulmonary blastoma.[2]

Historical Perspective

  • Pleuropulmonary blastoma was first discovered by Dr. Juan C. Manivel, MD in 1988.[3]

Classification

  • Pleuropulmonary blastoma may be classified into 3 groups:[2]
  • Type I: multicystic lesions
  • Type II: thickened areas (nodules) within cystic lesions
  • Type III: solid masses
  • Type I PPB is made up of mostly cysts, and may be hard to distinguish from benign lung cysts; not all type I PPB will progress to types II and III.

Pathophysiology

  • The pathogenesis of pleuropulmonary blastoma is characterized by resembling immature lung tissue.[2]
  • The p53 and DICER-1 gene mutations/deletions have been associated with the development of pleuropulmonary blastoma.[2]
  • On gross pathology, characteristic findings of pleuropulmonary blastoma include:[4]
  • On microscopic histopathological analysis, characteristic findings of pleuropulmonary blastoma include:
  • On inmunohistochemistry analysis, characteristic findings of pleuropulmonary blastoma include:[2]
  • Positive for TTF-1
  • Positive for vimentin
  • Positive for epithelial membrane antigen (EMA)

Causes

  • Common causes of pleuropulmonary blastoma include:[2]

Differentiating Pleuropulmonary Blastoma from Other Diseases

Epidemiology and Demographics

  • Pleuropulmonary blastoma is very uncommon.[2]

Age

  • Pleuropulmonary blastoma is more commonly observed among patients between 0-2 years old.
  • Pleuropulmonary blastoma is more commonly observed among infants and children.
  • Pleuropulmonary blastoma is less commonly observed among adults.[4]

Gender

  • Pleuropulmonary blastoma affects men and women equally.

Race

  • There is no racial predilection for pleuropulmonary blastoma

Risk Factors

  • There are no risk factors associated with the development of pleuropulmonary blastoma.[2]

Natural History, Complications and Prognosis

  • The majority of patients with pleuropulmonary blastoma are asymptomatic.
  • Pleuropulmonary blastoma is usually an incidental finding during routine examination.[4]
  • Early clinical features include persisting upper respiratory tract infection, coughing, and shortness of breath.
  • If left untreated, the majority of patients with may progress to develop acute respiratory distress syndrome.
  • Common complications of pleuropulmonary blastoma include respiratory failure, pneumonia, or mortality.
  • Prognosis is generally poor, and the 5-year survival rate of patients with pleuropulmonary blastoma is approximately 15%.
  • Pleuropulmonary blastomas larger than 5 cm have a worse prognosis.

Diagnosis

Symptoms

  • Pleuropulmonary blastoma is usually asymptomatic.
  • Symptoms of pleuropulmonary blastoma are often non-specific.
  • Symptoms of pleuropulmonary blastoma may include the following:[4]

Physical Examination

  • Patients with pleuropulmonary blastoma usually have dysmorphic facies.[4]
  • Physical examination may be remarkable for:

Laboratory Findings

  • There are no specific laboratory findings associated with pleuropulmonary blastoma.

Imaging Findings

  • CT is the imaging modality of choice for pleuropulmonary blastoma. On CT, findings of pleuropulmonary blastoma may include:
  • Large mass in the thorax with solid mixed cystic heterogeneous low attenuation
  • Pleural effusion
  • Contralateral mediastinal shift
  • Lack of chest wall invasion

Treatment

Medical Therapy

  • There is no treatment for pleuropulmonary blastoma; the mainstay of therapy is supportive care.[4]

Surgery

  • Surgery is the mainstay of therapy for pleuropulmonary blastoma.
  • Complete surgical resection is often most common approach to the treatment of pleuropulmonary blastoma.

Prevention

  • There are no primary preventive measures available for pleuropulmonary blastoma.[4]

References

  1. Indolfi P, Casale F, Carli M, et al. (September 2000). "Pleuropulmonary blastoma: management and prognosis of 11 cases". Cancer. 89 (6): 1396–401. doi:10.1002/1097-0142(20000915)89:6<1396::AID-CNCR25>3.0.CO;2-2. PMID 11002236.
  2. 2.0 2.1 2.2 2.3 2.4 2.5 2.6 2.7 Radiopedia. Dr. Henry Knipe. http://radiopaedia.org/articles/pleuropulmonary-blastoma Accessed on April 20, 2016
  3. Manivel JC, Priest JR, Watterson J, Steiner M, Woods WG, Wick MR; et al. (1988). "Pleuropulmonary blastoma. The so-called pulmonary blastoma of childhood". Cancer. 62 (8): 1516–26. PMID 3048630.
  4. 4.0 4.1 4.2 4.3 4.4 4.5 4.6 4.7 4.8 Dehner LP (1994). "Pleuropulmonary blastoma is THE pulmonary blastoma of childhood". Semin Diagn Pathol. 11 (2): 144–51. PMID 7809508.

Template:WS Template:WH